WS #12214
Holding: newest synthesis is 125d 1h old
Abbott beats Q2 estimates, raises full-year outlook, stock jumps 12%.
Abbott Laboratories Strong Earnings
Abbott beats Q2 estimates, raises full-year outlook, stock jumps 12%.
Abbott beats Q2 estimates, raises full-year outlook, stock jumps 12%.
Abbott beats Q2 estimates, raises full-year outlook, stock jumps 12%.